Skip to main content
DSS
NYSE Manufacturing

DSS 10-Q: Going Concern Warning, Revenue Down 44%, $39.1M Loan in Default

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
9
Price
$0.525
Mkt Cap
$5.274M
52W Low
$0.361
52W High
$1.86
52W Position info
46% above low
Off High info
72% below high
Rel. Volume
Market data snapshot near publication time

DSS sits 46% above its 52-week low of $0.361.

Summary

DSS reported a 44% drop in quarterly revenue, a $16.3 million nine-month net loss, and explicit going-concern doubt with only $3.3 million of cash against $42.8 million of negative working capital—while a $39.1 million mortgage remains in default.


Key Events · Earnings and Guidance · DSS

  • Going Concern Warning Disclosed

    Management states substantial doubt about the ability to continue as a going concern within one year, citing $3.3 million of cash and $42.8 million of negative working capital at September 30, 2026.

  • Revenue Falls 44% in Q3

    Third-quarter revenue dropped to $3.604 million from $6.392 million a year earlier; nine-month revenue fell 31% to $11.538 million from $16.630 million as packaging orders missed forecasts and REIT rental income shrank after facility sales.

  • Net Loss Widens to $16.3M

    Nine-month net loss was $16.311 million versus $10.087 million in 2025, including $1.44 million of stock-based compensation at Impact BioMedical; operating loss was $13.446 million.

  • $39.1M Mortgage Still in Default

    The AMRE LifeCare loan from Pinnacle Bank remains past due after a December 22, 2023 demand for payment; approximately $39.1 million of principal, accrued interest and costs is classified as current.


Analysis · DSS · Manufacturing

The going-concern language is now explicit: substantial doubt about DSS's ability to survive the next twelve months, with $3.3 million of cash against $42.8 million of negative working capital and $3.5 million burned in operations over nine months. Revenue is shrinking fast—third-quarter sales fell 44% to $3.6 million as packaging customers under-ordered and the REIT lost rental income from sold facilities—while the nine-month net loss widened to $16.3 million. On top of that, the $40.3 million Pinnacle Bank mortgage on the medical properties has been in default since a December 2023 demand, with roughly $39.1 million still owed and classified as current. Survival is being funded by related-party convertible notes from Alset (chairman Heng Fai Chan's vehicle), which convert at $0.45-$0.74 per share and came with tens of millions of warrants—paper that would swamp the current 10.0 million shares outstanding if exercised. This is a solvency story, not an earnings story.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 49.5% of the 210 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DSS was trading at $0.53 on NYSE in the Manufacturing sector, with a market capitalization of approximately $5.3M. The 52-week trading range was $0.36 to $1.86. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DSS - Latest Insights

DSS
Nov 10, 2026, 7:28 PM EST
Filing Type: DEF 14C
Importance Score:
8
Price at Filing: $0.4969
Real-time Price: $0.5252 info
Change: +$0.0283 (+6%) info
Market Cap: $5.274M info